Dabigatran Etexilate
Dabigatran Etexilate is a pharmaceutical drug with 69 clinical trials. Currently 5 active trials ongoing. Historical success rate of 96.4%.
Success Metrics
Based on 53 completed trials
Phase Distribution
Phase Distribution
37
Early Stage
8
Mid Stage
21
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
94.6%
53 of 56 finished
5.4%
3 ended early
5
trials recruiting
69
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE)
Dabigatran for Mitral Stenosis Atrial Fibrillation
A Study to Learn If the Study Medicine Called PF-08049820 Changes How the Body Processes the Other Study Medicines Called Oral Contraceptives, Midazolam, and Dabigatran in Healthy Adult Female Participants
A Study in Healthy People to Test Whether BI 1291583 Influences the Amount of Dabigatran in the Body
Evaluation of the Potential Drug-drug Interactions Between Gemfibrozil or Dabigatran Etexilate and Camlipixant
Clinical Trials (69)
THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE)
Dabigatran for Mitral Stenosis Atrial Fibrillation
A Study to Learn If the Study Medicine Called PF-08049820 Changes How the Body Processes the Other Study Medicines Called Oral Contraceptives, Midazolam, and Dabigatran in Healthy Adult Female Participants
A Study in Healthy People to Test Whether BI 1291583 Influences the Amount of Dabigatran in the Body
Evaluation of the Potential Drug-drug Interactions Between Gemfibrozil or Dabigatran Etexilate and Camlipixant
A Study in Healthy Men to Test the Influence of BI 1358894 on the Amount of the Medicines Rosuvastatin and Dabigatran in the Blood
Safety and Tolerability of Dabigatran Etexilate in Adolescents
A Study of Darunavir in Combination With Cobicistat or Ritonavir, and Dabigatran Etexilate in Healthy Participants
A Study to Understand the Effect of a Study Medicine Called ARV-471 on Dabigatran Etexilate in Healthy Adults
A Study to Learn About How BAY2927088 Affects the Level of Dabigatran or Rosuvastatin in the Blood When These Drugs Are Taken Together in Healthy Participants
Effect of Oral D-mannose Tablets on Pharmacokinetics of Dabigatranate in Healthy Adults
A Study in Healthy Men to Test the Influence of BI 1323495 on the Amount of the Medicines Rosuvastatin and Dabigatran in the Blood
A Study of Lasmiditan in Healthy Volunteers
Effect of Tepotinib on the PK of the P-gp Substrate Dabigatran Etexilate
Effect of Relacorilant on the Pharmacokinetics of the Sensitive P-glycoprotein Substrate Dabigatran Etexilate in Healthy Participants
Study to Assess the Effect of Co-Administration of AZD9833 on the Pharmacokinetics of Midazolam, of Omeprazole, of Celecoxib and of Dabigatran Etexilate in Healthy Postmenopausal Female Volunteers
A Study to Learn How the Study Drug Elinzanetant (BAY 3427080) Affects the Way the Drug Dabigatran Moves Into, Through and Out of the Body in Healthy Male and Female Participants
A Study to Examine the Effect of Daridorexant on the Way the Body Absorbs, Distributes, and Gets Rid of Dabigatran and Rosuvastatin in Healthy Male Subjects
Fruquintinib DDI Study With P-gp and BCRP Substrates
Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 69